These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24428351)

  • 1. A comparison between the HeRO graft and conventional arteriovenous grafts in hemodialysis patients.
    Nassar GM; Glickman MH; McLafferty RB; Croston JK; Zarge JI; Katzman HE; Peden EK; Lawson JH; Martinez JM; Thackeray L
    Semin Dial; 2014; 27(3):310-8. PubMed ID: 24428351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access.
    Brownie ER; Kensinger CD; Feurer ID; Moore DE; Shaffer D
    J Vasc Surg; 2016 Nov; 64(5):1392-1399. PubMed ID: 27444362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes comparison of HeRO and lower extremity arteriovenous grafts in patients with long-standing renal failure.
    Steerman SN; Wagner J; Higgins JA; Kim C; Mirza A; Pavela J; Panneton JM; Glickman MH
    J Vasc Surg; 2013 Mar; 57(3):776-83; discussion 782-3. PubMed ID: 23313186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Arm Swelling in Hemodialysis Patients with Ipsilateral Arteriovenous Access and Central Vein Stenosis: Conversion to the Hemodialysis Reliable Outflow Graft versus Stent Deployment.
    Cline BC; Gage SM; Ronald J; Pabon-Ramos WM; Dillavou ED; Smith TP; Lawson JH; Kim CY
    J Vasc Interv Radiol; 2020 Feb; 31(2):243-250. PubMed ID: 31706885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous interventions on the hemodialysis reliable outflow vascular access device.
    Gebhard TA; Bryant JA; Adam Grezaffi J; Pabon-Ramos WM; Gage SM; Miller MJ; Husum KW; Suhocki PV; Sopko DR; Lawson JH; Smith TP; Kim CY
    J Vasc Interv Radiol; 2013 Apr; 24(4):543-9. PubMed ID: 23462067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.
    Kakkos SK; Andrzejewski T; Haddad JA; Haddad GK; Reddy DJ; Nypaver TJ; Scully MM; Schmid DL
    J Vasc Surg; 2008 Feb; 47(2):407-14. PubMed ID: 18155874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The end stage of dialysis access: femoral graft or HeRO vascular access device.
    Kudlaty EA; Pan J; Allemang MT; Kendrick DE; Kashyap VS; Wong VL
    Ann Vasc Surg; 2015 Jan; 29(1):90-7. PubMed ID: 24952298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of stenting versus hemodialysis reliable outflow graft for hemodialysis patients with recurrent central venous obstructions.
    Proksch DM; Rodriguez LE; Rathore A; Steerman SN; Panneton JM
    J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1136-1144. PubMed ID: 33453441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report on the Hemodialysis Reliable Outflow (HeRO) experience in dialysis patients with central venous occlusions.
    Wallace JR; Chaer RA; Dillavou ED
    J Vasc Surg; 2013 Sep; 58(3):742-7. PubMed ID: 23591186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of HeRo catheter in catheter-dependent dialysis patients with superior vena cava occlusion.
    Davis KL; Gurley JC; Davenport DL; Xenos ES
    J Vasc Access; 2016; 17(2):138-42. PubMed ID: 26797902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular stent-graft treatment for graft-vein anastomotic stenosis in haemodialysis patients with arteriovenous grafts.
    Lin CH; Chen YY; Chua CH; Lu MJ
    Vasa; 2015 Nov; 44(6):466-72. PubMed ID: 26515224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper limb grafts for hemodialysis access.
    Shemesh D; Goldin I; Verstandig A; Berelowitz D; Zaghal I; Olsha O
    J Vasc Access; 2015; 16 Suppl 9():S34-9. PubMed ID: 25751548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary patencies of transposed femoral vein fistulas are significantly greater than with the HeRO graft.
    Ladenheim ED; Lulic D; Lum C; Agrawal S
    J Vasc Access; 2017 May; 18(3):232-237. PubMed ID: 28478626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of HeRO dialysis graft placement in a challenging population.
    Kokkosis AA; Abramowitz SD; Schwitzer J; Schanzer H; Teodorescu VJ
    Vasc Endovascular Surg; 2013 May; 47(4):278-80. PubMed ID: 23478878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of 6-mm straight grafts versus 6- to 8-mm tapered grafts for brachial-axillary dialysis access.
    Polo JR; Ligero JM; Diaz-Cartelle J; Garcia-Pajares R; Cervera T; Reparaz L
    J Vasc Surg; 2004 Aug; 40(2):319-24. PubMed ID: 15297828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of thrombectomy procedures performed in hemodialysis grafts with early failure.
    Yurkovic A; Cohen RD; Mantell MP; Kobrin S; Soulen MC; Chittams J; Trerotola SO
    J Vasc Interv Radiol; 2011 Mar; 22(3):317-24. PubMed ID: 21353985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity Increases the Risk of Primary Nonfunction and Early Access Loss, and Decreases Overall Patency in Patients Who Underwent Hemodialysis Reliable Outflow Device Placement.
    Naffouje SA; Tzvetanov I; Bui JT; Gaba R; Bernardo K; Jeon H
    Ann Vasc Surg; 2016 Oct; 36():236-243. PubMed ID: 27421202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Flixene vascular access graft as an early cannulation solution.
    Berard X; Ottaviani N; Brizzi V; Deglise S; de Precigout V; Ducasse E; Combe C; Midy D
    J Vasc Surg; 2015 Jul; 62(1):128-34. PubMed ID: 25770983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts.
    Woo K; Doros G; Ng T; Farber A
    J Vasc Surg; 2009 Dec; 50(6):1405-11.e1-2. PubMed ID: 19782518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study.
    Conte MS; Nugent HM; Gaccione P; Guleria I; Roy-Chaudhury P; Lawson JH
    J Vasc Surg; 2009 Dec; 50(6):1359-68.e1. PubMed ID: 19958986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.